Ever since UniQuest granted a license to ATH for its zinc ionophore technology 6 months ago I always felt it was likely that a partnership with a big pharmaceutical company would happen. Assuming it does, the only question is what form does it take. I only hope that multiple pharmaceutical companies are tripping over themselves to be 'the chosen one'.
Antibiotic resistance fund aims 2-4 new antibiotics by 2030, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.98M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $9.545K | 2.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 78688152 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28597616 | 27 |
View Market Depth
| Last trade - 12.21pm 25/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |